This article brings together two streams of research which have had important developments over the past years without coming together around a single empirical object. The first of these streams has developed in economic sociology around questions of valuation and pricing (Aspers and Beckert, 2011; Hegelsson and Muniesa, 2013; Vatin, 2013). If the majority of these works are more interested in processes of qualification than in processes of pricing, this gap tends to be filled by studies that are primarily focused on the formation, the circulation and the social uses of prices (Beckert, 2011; Chauvin, 2011 and previous issue). However, as Beckert (2011) emphasizes, these works have often neglected the role of institutions in general, and o...
For decades, the focus of modern political history was restricted to the realm of politics, emphasiz...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...
International audienceThis article examines the pricing of reimbursed prescription drugs in France f...
This article examines how prices for pharmaceuticals reimbursed by the state in France have been det...
This article studies the evolution of drug pricing by the French State since 1948. While the objecti...
The article examines whether and how independent regulatory agencies (IRAs) have altered the strateg...
Price regulation and competition patterns in the ethical drug industry in france This article gives...
A partir de la mesure des élasticités-prix et des élasticités-promotion au sein d'un modèle économét...
Considering that the definitions of politics which dominate political economy are actually synonyms ...
Dans l’objectif d’augmenter le bien-être des individus qu’ils représentent, les pouvoirs publics enc...
The article compares independent regulatory agencies (IRAs) for markets in France and Britain. It re...
La thèse examine les configurations d'acteurs et d'organisations impliquées dans la régulation de l'...
International audienceBACKGROUND:In 2005, the French Government implemented a new way of financing h...
Cette thèse s’intéresse, d'une part à la question de la maîtrise des dépenses de médicaments, et d'a...
For decades, the focus of modern political history was restricted to the realm of politics, emphasiz...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...
International audienceThis article examines the pricing of reimbursed prescription drugs in France f...
This article examines how prices for pharmaceuticals reimbursed by the state in France have been det...
This article studies the evolution of drug pricing by the French State since 1948. While the objecti...
The article examines whether and how independent regulatory agencies (IRAs) have altered the strateg...
Price regulation and competition patterns in the ethical drug industry in france This article gives...
A partir de la mesure des élasticités-prix et des élasticités-promotion au sein d'un modèle économét...
Considering that the definitions of politics which dominate political economy are actually synonyms ...
Dans l’objectif d’augmenter le bien-être des individus qu’ils représentent, les pouvoirs publics enc...
The article compares independent regulatory agencies (IRAs) for markets in France and Britain. It re...
La thèse examine les configurations d'acteurs et d'organisations impliquées dans la régulation de l'...
International audienceBACKGROUND:In 2005, the French Government implemented a new way of financing h...
Cette thèse s’intéresse, d'une part à la question de la maîtrise des dépenses de médicaments, et d'a...
For decades, the focus of modern political history was restricted to the realm of politics, emphasiz...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...
Cet article examine la fixation des prix des médicaments remboursés par l’État, en France, depuis se...